不妊治療薬の世界市場規模調査＆予測：薬物クラス（ゴナドトロフィン、アロマターゼ阻害剤、選択的エストロゲン受容体モジュレーター、ビグアナイド、その他）、エンドユーザー、流通チャネル、地域分析別、2022-2029年

不妊治療薬とは、不妊症の治療や生殖機能の改善を目的として使用される一群の医薬品を指します。

飲み薬と点滴があります。ゴナドトロフィン、ドーパミン作動薬、アロマターゼ阻害薬、ビグアナイド系薬剤、排卵誘発剤、選択的エストロゲン受容体モジュレーター（SERM）、三環系抗うつ薬などは、不妊治療に頻繁に使用されている薬剤の一例です。不妊治療薬市場は、ヘルスケアに対する意識の高まり、女性の高齢化、ストレスや生活習慣病の男女比の増加により、大きく拡大すると予想されています。

米国の国立薬物乱用統計センターによると、COVID-19のロックダウン期間中、米国人の約60.0%がアルコール摂取量を増やしたことが判明しています。同じように、2021年に世界保健機関が出した調査によると、中国の喫煙者は3億人以上で、当時の世界人口の3分の1以上だったそうです。中国では、15歳以上の成人のうち、喫煙者は約26.6％いました。ホルモンバランスの乱れ、多嚢胞性卵巣疾患、体重の問題など、胚に直接影響を及ぼし、不妊症の心配がある場合、健康的なライフスタイルが大きな要因のひとつになります。一方、男性の総運動精子数が正常である割合は、過去16年間で約10％減少しています。現代の男性は、昔に比べて健全な精子を生成することが少なくなっていることは明らかです。しかし、製品の認可を妨げる厳しい規制構造が、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

不妊治療薬の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米は、更年期障害や市場関係者の集中、メーカーの存在感などから、市場全体のシェアをリードしています。しかし、アジア太平洋地域は、医療費の増加や発展途上国における不妊治療の普及を目的とした政府の取り組みにより、最も急速に成長している地域であると予想されます。

本レポートに含まれる主な市場参入企業は以下の通りです。

• Abbott Laboratories
• Ferring Pharmaceuticals Inc.
• Merck KGaA
• Pfizer Inc.
• Novartis International AG
• Bayer AG
• Theramex
• Mankind Pharma
• Teva Pharmaceuticals Industries
• Livzon

本調査の目的は、近年における様々なセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における業界の質的・量的な側面を取り込むことを目的としています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します。

薬物クラス別

ゴナドトロフィン

アロマターゼ阻害剤

選択的エストロゲン受容体モジュレーター（SERMs）

ビグアナイド

その他の薬物クラス

エンドユーザー別

男性

女性

販売チャネル別

病院内薬局

小売店

その他の流通チャネル

地域別

北米

米国

カナダ

欧州

英国

ドイツ

フランス

スペイン

イタリア

その他欧州

アジア太平洋地域

中国

インド

日本

オーストラリア

韓国

その他アジア太平洋

ラテンアメリカ

ブラジル

メキシコ

世界のその他の地域

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019-2029年
  • 不妊治療薬市場（地域別）：2019-2029年
  • 不妊治療薬市場（薬物クラス別）：2019-2029年
  • 不妊治療薬市場：エンドユーザー別、2019-2029年
  • 不妊治療薬市場：流通チャネル別、2019-2029年
• 主な動向
• 調査手法の紹介
• 調査前提条件

第2章 不妊治療薬の世界市場：定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 不妊治療薬の世界市場力学

• 不妊治療薬市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 女性の高齢化に伴うヘルスケアに対する意識の高まり
    • ストレスや生活習慣病の男女比の増加
  • 市場の課題
    • 製品の認可を妨げる厳しい規制構造
  • 市場機会
    • 不妊症・流産率の上昇
    • 不妊治療薬開発のための公的資金提供の増加

第4章 不妊治療薬の世界市場：産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• 投資採用モデル
• アナリストの結論・提言
• トップ投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 不妊治療薬の世界市場：薬物クラス別

• 市場スナップショット
• 不妊治療薬の世界市場：薬物クラス別、業績-ポテンシャル分析
• 不妊治療薬の世界市場、薬物クラス別推定・予測2019-2029
• 不妊治療薬市場、サブセグメント分析
  • ゴナドトロフィン
  • アロマターゼ阻害剤
  • 選択的エストロゲン受容体モジュレーター（SERMs）
  • ビグアナイド
  • その他の薬物クラス

第7章 不妊治療薬の世界市場：エンドユーザー別

• 市場スナップショット
• 不妊治療薬の世界市場：エンドユーザー別実績-ポテンシャル分析
• 不妊治療薬の世界市場、エンドユーザー別推定・予測2019-2029
• 不妊治療薬市場、サブセグメント分析
  • 男性
  • 女性

第8章 不妊治療薬の世界市場：流通チャネル別

• 市場スナップショット
• 不妊治療薬の世界市場：流通チャネル別実績-ポテンシャル分析
• 不妊治療薬の世界市場、流通チャネル別推定・予測（2019-2029年
• 不妊治療薬市場、サブセグメント分析
  • 病院内薬局
  • 小売薬局
  • その他の流通チャネル

第9章 不妊治療薬の世界市場：地域別分析

• 不妊治療薬の市場、地域別市場スナップショット
• 北米
  • 米国
    • 薬物クラス別の推定・予測、2019年～2029年
    • エンドユーザー別の推定・予測、2019年～2029年
    • 流通チャネル別の推定・予測、2019年～2029年
  • カナダ
• 欧州の不妊治療薬市場のスナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の不妊治療薬市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの不妊治療薬市場スナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Teva Pharmaceuticals Industries
    • 主な情報
    • 概要
    • 財務（データの入手が可能な場合）
    • 製品概要
    • 最近の開発状況
  • Abbott Laboratories
  • Mankind Pharma
  • Merck KGaA
  • Ferring Pharmaceuticals Inc.
  • Novartis International AG
  • Livzon
  • Pfizer Inc.
  • Theramex
  • Bayer AG

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Infertility Drugs Market, report scope
• TABLE 2. Global Infertility Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Infertility Drugs Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Infertility Drugs Market estimates & forecasts by End User 2019-2029 (USD Billion)
• TABLE 5. Global Infertility Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 6. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Infertility Drugs Market
• TABLE 71. List of primary sources, used in the study of global Infertility Drugs Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Infertility Drugs Market, research methodology
• FIG 2. Global Infertility Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Infertility Drugs Market, key trends 2021
• FIG 5. Global Infertility Drugs Market, growth prospects 2022-2029
• FIG 6. Global Infertility Drugs Market, porters 5 force model
• FIG 7. Global Infertility Drugs Market, pest analysis
• FIG 8. Global Infertility Drugs Market, value chain analysis
• FIG 9. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Infertility Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Infertility Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Infertility Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2022-2029. The term "infertility medicines" refers to a group of pharmaceuticals that are used to treat infertility and improve a person's reproductive health. They can be swallowed or administered intravenously. Gonadotrophins, dopamine agonists, aromatase inhibitors, biguanides, ovulatory stimulants, selective oestrogen receptor modulators (SERMs), and tricyclic antidepressants are a few of the medications that are frequently used to treat infertility. The infertility drugs market is anticipated to expand significantly owing to upsurge in Healthcare Awareness along with increasing aging female population and growing prevalence of stress and life-style disorders among men and women.

The National Center for Drug Abuse Statistics found that during the COVID-19 lockdowns, almost 60.0% of Americans increased their alcohol intake. In a similar vein, according to a study issued by the World Health Organization in 2021, China had more than 300.0 million smokers, or over one-third of the world's population at the time. In China, there were around 26.6% of adults who smoked who were 15 years of age or older. One of the major contributors to hormonal imbalance, polycystic ovarian disease, and weight problems, which have an immediate influence on the embryo and might cause infertility concerns, is a healthy lifestyle. On the other side, over the past 16 years, the percentage of males with a normal total motile sperm count has decreased by around 10%. The evidence is clear: Men today generate less and less healthy sperm than in the past. However, strict regulatory structure that impedes the approval of products stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Infertility Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to menopausal disorders and high concentration of market players or manufacturer's presence. However, Asia Pacific expected to be the fastest growing region owing to rising healthcare expenditures and initiatives by the government to increase the availability of the infertility treatment in the developing nations.

Major market players included in this report are:

Abbott Laboratories

Ferring Pharmaceuticals Inc.

Merck KGaA

Pfizer Inc.

Novartis International AG

Bayer AG

Theramex

Mankind Pharma

Teva Pharmaceuticals Industries

Livzon

Recent Developments in the Market:

• In order to sell Genea Biomedx's (Australia) fertility products in the US and Canada, Genea Biomedx (Australia) partnered with Hamilton Thorne in 2020.
• In August 2021, Merck introduced Pergoveris Pen in India for the treatment of infertility. The Pergoveris Pen is the first item to ever include both recombinant follicle-stimulating hormone and recombinant luteinizing hormone in a ready-to-use, IVF specialist-prescribed device. A pen with bulk technology that has received international approval offers infertile couples a more secure self-service infertility option.

Global Infertility Drugs Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug class, End User, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Gonadotrophins

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Other Drug Classes

By End User:

Male

Female

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Other Distribution Channels

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Infertility Drugs Market, by region, 2019-2029 (USD Billion)
  • 1.2.2. Infertility Drugs Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Infertility Drugs Market, by End User, 2019-2029 (USD Billion)
  • 1.2.4. Infertility Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Infertility Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Infertility Drugs Market Dynamics

• 3.1. Infertility Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Upsurge in Healthcare Awareness along with Increasing Aging Female Population
    • 3.1.1.2. Growing Prevalence of Stress and Life-style Disorders among Men and Women
  • 3.1.2. Market Challenges
    • 3.1.2.1. Strict Regulatory Structure that Impedes the Approval of Products
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising incidences of infertility and miscarriage
    • 3.1.3.2. Increasing public funding for developing these drugs

Chapter 4. Global Infertility Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Infertility Drugs Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Infertility Drugs Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Infertility Drugs Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Infertility Drugs Market, Sub Segment Analysis
  • 6.4.1. Gonadotrophins
  • 6.4.2. Aromatase Inhibitors
  • 6.4.3. Selective Estrogen Receptor Modulators (SERMs)
  • 6.4.4. Biguanides
  • 6.4.5. Other Drug Classes

Chapter 7. Global Infertility Drugs Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Infertility Drugs Market by End User, Performance - Potential Analysis
• 7.3. Global Infertility Drugs Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
• 7.4. Infertility Drugs Market, Sub Segment Analysis
  • 7.4.1. Male
  • 7.4.2. Female

Chapter 8. Global Infertility Drugs Market, by Distribution Channel

• 8.1. Market Snapshot
• 8.2. Global Infertility Drugs Market by Distribution Channel, Performance - Potential Analysis
• 8.3. Global Infertility Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 8.4. Infertility Drugs Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Retail Pharmacies
  • 8.4.3. Other Distribution Channels

Chapter 9. Global Infertility Drugs Market, Regional Analysis

• 9.1. Infertility Drugs Market, Regional Market Snapshot
• 9.2. North America Infertility Drugs Market
  • 9.2.1. U.S. Infertility Drugs Market
    • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. End User breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Infertility Drugs Market
• 9.3. Europe Infertility Drugs Market Snapshot
  • 9.3.1. U.K. Infertility Drugs Market
  • 9.3.2. Germany Infertility Drugs Market
  • 9.3.3. France Infertility Drugs Market
  • 9.3.4. Spain Infertility Drugs Market
  • 9.3.5. Italy Infertility Drugs Market
  • 9.3.6. Rest of Europe Infertility Drugs Market
• 9.4. Asia-Pacific Infertility Drugs Market Snapshot
  • 9.4.1. China Infertility Drugs Market
  • 9.4.2. India Infertility Drugs Market
  • 9.4.3. Japan Infertility Drugs Market
  • 9.4.4. Australia Infertility Drugs Market
  • 9.4.5. South Korea Infertility Drugs Market
  • 9.4.6. Rest of Asia Pacific Infertility Drugs Market
• 9.5. Latin America Infertility Drugs Market Snapshot
  • 9.5.1. Brazil Infertility Drugs Market
  • 9.5.2. Mexico Infertility Drugs Market
• 9.6. Rest of The World Infertility Drugs Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Teva Pharmaceuticals Industries
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Abbott Laboratories
  • 10.2.3. Mankind Pharma
  • 10.2.4. Merck KGaA
  • 10.2.5. Ferring Pharmaceuticals Inc.
  • 10.2.6. Novartis International AG
  • 10.2.7. Livzon
  • 10.2.8. Pfizer Inc.
  • 10.2.9. Theramex
  • 10.2.10. Bayer AG

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption